Atlas Trials

A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.

Clinical trial NCT01164384 · UNKNOWN

Trial details

NCT number
NCT01164384
Sponsor
University of Zurich
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic HCV Hepatitis C
Start date
2010-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.